An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al.
Kanna
Balavenkatesh
B
Abreu-Pacheco
Heidi
H
D000280:Administration, Inhalation; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008687:Metformin / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
C473734:Exubera; D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin; D005905:Glyburide